New Zealand markets closed

Oramed Pharmaceuticals Inc. (ORMP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.2400+0.0100 (+0.45%)
At close: 04:00PM EDT
2.1900 -0.05 (-2.23%)
After hours: 05:20PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/08/2021
31/08/2020
31/08/2019
Total revenue
674
1,340
2,703
2,703
2,710
-
Cost of revenue
-
-
-
-
0
90
Gross profit
-
-
-
-
2,710
2,613
Operating expenses
Research development
5,723
8,971
27,639
20,989
10,235
-
Selling general and administrative
8,474
8,138
15,662
5,937
4,232
-
Total operating expenses
14,197
17,109
43,301
26,926
14,467
-
Operating income or loss
-13,523
-15,769
-40,598
-24,223
-11,757
-
Interest expense
2,629
2,037
0
-
-
-
Total other income/expenses net
-
16,268
-630
893
-438
-
Income before tax
10,233
5,088
-37,664
-22,989
-11,511
-
Income tax expense
-
0
100
-
0
300
Income from continuing operations
10,233
5,088
-37,764
-22,989
-11,511
-
Net income
10,456
5,525
-36,561
-22,238
-11,511
-
Net income available to common shareholders
10,456
5,525
-36,561
-22,238
-11,511
-
Basic EPS
-0.41
0.14
-0.94
-0.78
-0.56
-
Diluted EPS
-0.41
0.14
-0.94
-0.78
-0.56
-
Basic average shares
40,040
40,315
38,998
28,469
20,532
-
Diluted average shares
40,040
40,567
38,998
28,469
20,532
-